FORESITE CAPITAL
Foresite Capital their funding includes developing generation therapeutics.
FORESITE CAPITAL
Industry:
Finance Financial Services Funding Platform Service Industry Venture Capital
Founded:
2011-01-01
Status:
Active
Contact:
+1 415-877-4887
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Haystack
Haystack is a venture capital firm that backs outlier founders at the earliest stages.
Highlight Capital
Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.
Marquette Capital Partners
Marquette Capital provides flexible junior capital solutions in support of lower-middle-market companies throughout the United States.
Patriot Capital
Patriot Capital provides debt and equity capital in acquisitions, management buyouts and recapitalizations.
SaaS Capital
Premier provider of alternative growth capital to growing SaaS companies.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-18 | Delfi Diagnostics | Foresite Capital investment in Series B - Delfi Diagnostics | 225 M USD |
| 2022-06-21 | Myome | Foresite Capital investment in Series B - Myome | 23 M USD |
| 2022-05-17 | Mirvie | Foresite Capital investment in Series B - Mirvie | 45 M USD |
| 2022-05-17 | Remix Therapeutics | Foresite Capital investment in Series B - Remix Therapeutics | 70 M USD |
| 2022-05-16 | Kriya Therapeutics | Foresite Capital investment in Series C - Kriya Therapeutics | 270 M USD |
| 2022-03-08 | DNAnexus | Foresite Capital investment in Series H - DNAnexus | 200 M USD |
| 2022-01-27 | TenSixteen Bio | Foresite Capital investment in Series A - TenSixteen Bio | 40 M USD |
| 2022-01-20 | ImmPACT Bio | Foresite Capital investment in Series B - ImmPACT Bio | 111 M USD |
| 2022-01-10 | Maze Therapeutics | Foresite Capital investment in Venture Round - Maze Therapeutics | 190 M USD |
| 2022-01-06 | Eikon Therapeutics | Foresite Capital investment in Series B - Eikon Therapeutics | 518 M USD |